Savara Inc (NASDAQ: SVRA) is 17.23% higher on its value in year-to-date trading and has touched a low of $1.63 and a high of $5.44 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SVRA stock was last observed hovering at around $5.16 in the last trading session, with the day’s gains setting it 0.35%.
Currently trading at $5.51, the stock is 11.39% and 15.96% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.49 million and changing 6.78% at the moment leaves the stock 45.70% off its SMA200. SVRA registered 115.23% gain for a year compared to 6-month gain of 52.21%. The firm has a 200-day simple moving average (SMA200) of -$10.65.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 8.89% loss in the last 1 month and extending the period to 3 months gives it a 43.12%, and is 5.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.71% over the week and 4.35% over the month.
Savara Inc (SVRA) has around 28 employees, a market worth around $745.72M and $0.00M in sales. Distance from 52-week low is 238.04% and 1.29% from its 52-week high. The company has generated returns on investments over the last 12 months (-28.29%).
Savara Inc quarterly earnings per share for the current quarter are estimated at -$0.1.The EPS is expected to shrink by -40.67% this year.
Savara Inc (SVRA) Top Institutional Holders
133 institutions hold shares in Savara Inc (SVRA), with institutional investors hold 93.65% of the company’s shares. The shares outstanding are 114.05M, and float is at 65.38M with Short Float at 4.15%. Institutions hold 88.25% of the Float.
The top institutional shareholder in the company is NEA Management Company, LLC with over 24.14 million shares valued at $77.12 million. The investor’s holdings represent 17.86% of the SVRA Shares outstanding. As of Jun 29, 2023, the second largest holder is Bain Capital Life Sciences Investors, LLC with 11.62 million shares valued at $37.13 million to account for 8.60% of the shares outstanding. The other top investors are Farallon Capital Management Llc which holds 10.91 million shares representing 8.07% and valued at over $34.85 million, while VR Adviser, LLC holds 4.70% of the shares totaling 6.35 million with a market value of $20.29 million.
Savara Inc (SVRA) Insider Activity
A total of 0 insider transactions have happened at Savara Inc (SVRA) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by Elam Nevan C,the company’sDirector. SEC filings show that Elam Nevan C sold 93,843 shares of the company’s common stock on Dec 28 at a price of $4.71 per share for a total of $0.44 million. Following the sale, the insider now owns 22500.0 shares.
Savara Inc disclosed in a document filed with the SEC on Dec 28 that Pauls Matthew (CHIEF EXECUTIVE OFFICER) sold a total of 84,000 shares of the company’s common stock. The trade occurred on Dec 28 and was made at $4.71 per share for $0.4 million. Following the transaction, the insider now directly holds 1.3 million shares of the SVRA stock.
Still, SEC filings show that on Dec 28, Lowrance David L (CHIEF FINANCIAL OFFICER) disposed off 10,000 shares at an average price of $4.71 for $47131.0. The insider now directly holds 342,355 shares of Savara Inc (SVRA).
Savara Inc (SVRA): Who are the competitors?
The company’s main competitors (and peers) include Eli Lilly & Co. (LLY) that is trading 148.39% up over the past 12 months. Sangamo Therapeutics Inc. (SGMO) that is -60.00% lower over the same period.
